Citadel Advisors’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.54M Buy
129,106
+54,056
+72% +$553K ﹤0.01% 6656
2025
Q4
$747K Buy
+75,050
New +$717K ﹤0.01% 8063
2025
Q2
Sell
-310,004
Closed -$2.74M 12358
2025
Q1
$3.36M Buy
310,004
+173,602
+127% +$1.75M ﹤0.01% 4562
2024
Q4
$1.3M Sell
136,402
-243,448
-64% -$2.46M ﹤0.01% 6509
2024
Q3
$4.27M Buy
379,850
+77,621
+26% +$825K ﹤0.01% 4204
2024
Q2
$3.02M Buy
+302,229
New +$3.07M ﹤0.01% 4552
2024
Q1
Sell
-22,130
Closed -$188K 14482
2023
Q4
$161K Sell
22,130
-155,721
-88% -$1.23M ﹤0.01% 10272
2023
Q3
$1.62M Sell
177,851
-276,342
-61% -$3.31M ﹤0.01% 5606
2023
Q2
$5.53M Sell
454,193
-663,488
-59% -$7.39M ﹤0.01% 3499
2023
Q1
$13.9M Buy
1,117,681
+809,152
+262% +$14.9M ﹤0.01% 2376
2022
Q4
$5.93M Sell
308,529
-101,789
-25% -$2.15M ﹤0.01% 3582
2022
Q3
$7.71M Sell
410,318
-172,235
-30% -$3.54M ﹤0.01% 3145
2022
Q2
$10.5M Sell
582,553
-185,385
-24% -$3.01M ﹤0.01% 2623
2022
Q1
$12.3M Buy
767,938
+727,664
+1,807% +$13.1M ﹤0.01% 2642
2021
Q4
$985K Sell
40,274
-182,987
-82% -$4.3M ﹤0.01% 7996
2021
Q3
$5.2M Buy
223,261
+160,730
+257% +$3.89M ﹤0.01% 4223
2021
Q2
$1.71M Sell
62,531
-61,229
-49% -$1.75M ﹤0.01% 6981
2021
Q1
$4.55M Buy
123,760
+43,176
+54% +$1.53M ﹤0.01% 4454
2020
Q4
$3.03M Sell
80,584
-72,410
-47% -$2.24M ﹤0.01% 4572
2020
Q3
$3.34M Buy
152,994
+94,794
+163% +$1.99M ﹤0.01% 3807
2020
Q2
$937K Buy
58,200
+47,825
+461% +$799K ﹤0.01% 5948
2020
Q1
$166K Buy
+10,375
New +$147K ﹤0.01% 8191

Other funds holding AHCO

Citadel Advisors's AHCO Position: Q1 2026 in Review

Citadel Advisors increased its AdaptHealth (AHCO) stake by 72% in Q1 2026, buying an estimated $553K and bringing the position to 129,106 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #6656.

Citadel Advisors first reported a position in AHCO in Q1 2020 and has held it in 22 quarters since. The position peaked at $13.9M in Q1 2023. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Citadel Advisors held 129,106 shares of AdaptHealth worth $1.54M as of Q1 2026.
  • Citadel Advisors bought 54,056 AdaptHealth shares in Q1 2026, an estimated $553K.
  • AdaptHealth made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6656 holding.
  • Citadel Advisors first reported a position in AdaptHealth in Q1 2020 and has held it in 22 quarters since.
  • Citadel Advisors's AdaptHealth position peaked at $13.9M in Q1 2023.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.